Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

The co-leader of President-elect Donald Trump’s initiative to cut government spending has a financial stake in the biotech ...

Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...

The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...

Federal officials said they found black mold and disease-causing bacteria in a popular brand of toothpaste. In a letter dated ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump picks heads of CDC, FDA and ...

Ashish Jha, the dean of the Brown University School of Public Health and former White House coronavirus coordinator under ...

Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, ...

Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...

Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...